George Simeon, CEO
George Simeon, CEO of Curevo and experienced business executive in the healthcare industry. Has worked globally with Novartis (Switzerland), J&J (Europe), SK Telecom (South Korea), GHX (Europe) and GS1 (USA & Europe). Advisor to early stage companies on growth strategies, strategic alliances, fundraising, and market entry.
Lisa Shelton, Associate Director Clinical Operations
Lisa Shelton, Associate Director of Clinical Operations and Licensed Adult Nurse Practitioner (ARNP). A successful leader in clinical trials investigation and study management in both sponsor and clinical site roles. Sponsor roles in clinical development and operations of first-in-human, phase 1 vaccine, and immunotherapy oncology studies. Experienced sub-investigator for first-in-human, and phase 1-3 trials in infectious disease vaccine and immunotherapy allergy trials.
Soobin Koh, Regulatory Affairs Manager
Soobin Koh, Regulatory Affairs Manager at Curevo. Global regulatory Affairs specialist with experience managing regulatory affairs from product development R&D to pre-market application.
Emma Fritzen, Senior Program Manager
Emma Fritzen is the Senior Program Manager for Curevo, and has proven experience developing and managing contracts, scope and budget in clinical operations. Emma also has experience with GMP and laboratory oversight, management of teams, and represents Clinical Operations in cross-functional initiatives.
Nikki Turakhia, Clinical Operations Manager
Nikki is a clinical research specialist with experience in coordinating phase I, II & III oncology and sleep disorder trials. Over past 10 years, Nikki has worked as a formulation chemist in cosmetic industry and as a clinical research coordinator at clinical sites. Her expertise lies in formulation, project management, and implementing efficient, high-impact, and well-organized clinical studies.
Anna Wrem, Program Manager
Anna Wrem is the Program Manager at Curevo. She has extensive experience in laboratory operations, cradle-to-grave management of grants and contracts from various funding sources, budget projections and analysis within the research and development setting.